Literature DB >> 2897914

Heart rate reduction--a mechanism of benefit?

J Kjekshus1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2897914     DOI： 10.1093/eurheartj/8.suppl_l.115

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

Review 1.  Potential interests of heart rate lowering drugs.

Authors:  T Laperche; D Logeart; A Cohen-Solal; R Gourgon
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

2.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

3.  Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Philipp Ehlermann; Hugo A Katus; Andreas O Doesch
Journal:  Clin Res Cardiol       Date:  2017-11-02       Impact factor: 5.460

4.  [Heart rate reduction as a therapeutic strategy: novel options].

Authors:  U C Hoppe
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

5.  Benefit of heart rate reduction in heart failure.

Authors:  Gerd Hasenfuss
Journal:  Curr Heart Fail Rep       Date:  2010-12

Review 6.  Left ventricular function and prognosis after myocardial infarction: rationale for therapeutic strategies.

Authors:  R Scognamiglio; G Fasoli; S Nistri; M Marin; S Dalla Volta
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

Review 7.  Current and future status of beta-blockers in the treatment of hypertension.

Authors:  Steven G Chrysant; George S Chrysant; Billy Dimas
Journal:  Clin Cardiol       Date:  2008-06       Impact factor: 2.882

Review 8.  Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.

Authors:  Dario DiFrancesco; John A Camm
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Perioperative beta-blockers for preventing surgery-related mortality and morbidity.

Authors:  Hermann Blessberger; Juergen Kammler; Hans Domanovits; Oliver Schlager; Brigitte Wildner; Danyel Azar; Martin Schillinger; Franz Wiesbauer; Clemens Steinwender
Journal:  Cochrane Database Syst Rev       Date:  2018-03-13

Review 10.  Cardioprotection: the role of beta-blocker therapy.

Authors:  Brent M Egan; Jan Basile; Robert J Chilton; Jerome D Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.